Market Research Reports and Industry Reports

Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Report 2017

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
In this report, the Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Benign Prostatic Hyperplasia (BPH) Treatment Devices for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices market competition by top manufacturers/players, with Benign Prostatic Hyperplasia (BPH) Treatment Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Endo International (US)
Karl Storz (Germany)
Medtronic (US)
Siemens (Germany)
Lumenis (Israel)
Olympus (Japan)
Urologix (US)
NeoTract (US)
Boston Scientific (US)
Urotech (Germany)
Toshiba (Japan)
Baxter International (US)

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Laser Based Procedure
Other Energy Based Procedure

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Benign Prostatic Hyperplasia (BPH) Treatment Devices for each application, includin
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Other

If you have any special requirements, please let us know and we will offer you the report as you want.



Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Report 2017
1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Overview
1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Treatment Devices
1.2 Classification of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product Category
1.2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Laser Based Procedure
1.2.4 Other Energy Based Procedure
1.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market by Application/End Users
1.3.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Other
1.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market by Region
1.4.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Benign Prostatic Hyperplasia (BPH) Treatment Devices (2012-2022)
1.5.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume and Value) by Type
2.2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume) by Application
2.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume and Value) by Region
2.4.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Region (2012-2017)

3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
3.1 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
3.1.1 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
3.1.2 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
3.1.3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
3.2 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
3.3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

4 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
4.1 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
4.1.1 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
4.1.3 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
4.2 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
4.3 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

5 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
5.1 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
5.1.1 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
5.2 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
5.3 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

6 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
6.1 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
6.1.1 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
6.2 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
6.3 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

7 India Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
7.1 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
7.1.1 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
7.1.2 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
7.1.3 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
7.2 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
7.3 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

8 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
8.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
8.1.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
8.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
8.3 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

9 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
9.1 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
9.1.1 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
9.1.3 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
9.2 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
9.3 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

10 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Players/Suppliers Profiles and Sales Data
10.1 Endo International (US)
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Karl Storz (Germany)
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Medtronic (US)
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Siemens (Germany)
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Lumenis (Israel)
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Olympus (Japan)
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Urologix (US)
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 NeoTract (US)
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Boston Scientific (US)
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Urotech (Germany)
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Toshiba (Japan)
10.12 Baxter International (US)

11 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Cost Analysis
11.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2017-2022)
15.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer



List Of Tables

List of Tables and Figures

Figure Product Picture of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (Product Category) in 2016
Figure Laser Based Procedure Product Picture
Figure Other Energy Based Procedure Product Picture
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Ambulatory Surgical Centers Examples
Table Key Downstream Customer in Ambulatory Surgical Centers
Figure Specialty Clinics Examples
Table Key Downstream Customer in Specialty Clinics
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Million USD) by Region (2012-2022)
Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Players/Suppliers
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Players
Figure 2017 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Players
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Type (2012-2017)
Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2012-2017)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2012-2017)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Region (2012-2017)
Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region (2012-2017)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region in 2016
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region (2012-2017)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region in 2016
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2012-2017)
Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
Table China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
Table China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
Table China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
Table China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
Table Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
Table Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
Table Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
Table South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
Table South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
Table Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
Table India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
Table India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
Table India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Application (2012-2017)
Table India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
Table Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
Table Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
Table Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
Table Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis
Table Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Manufacturers in 2016
Table Major Buyers of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Table Distributors/Traders List
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Region in 2022
Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


Asia-Pacific X-ray Inspection Systems Market Report 2017

In this report, the Asia-Pacific X-ray Inspection Systems market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

USD 4000View Report

Asia-Pacific Wriggle Pumps Market Report 2017

In this report, the Asia-Pacific Wriggle Pumps market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing

USD 4000View Report

Benign Prostatic Hyperplasia - Pipeline Review, H2 2017

Benign Prostatic Hyperplasia - Pipeline Review, H2 2017Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Benign Prostatic Hyperplasia - Pipeline Review, H2 2017, provides an overview of the

USD 2000View Report

Global Benign Prostatic Hyperplasia (BPH) Drugs Market Professional Survey Report 2017

This report studies Benign Prostatic Hyperplasia (BPH) Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in

USD 3500View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 4000
  • Global Licence    USD 8000
$ 4000

Reports Details

Published Date : Aug 2017
No. of Pages :118
Country :Asia-Pacific
Category :Medical Devices
Publisher :QYResearch Group
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube